VIKING GLOBAL INVESTORS LP - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
VIKING GLOBAL INVESTORS LP ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$163,465,709
-18.8%
29,993,7080.0%0.66%
-19.5%
Q2 2023$201,257,781
-24.0%
29,993,7080.0%0.82%
-33.7%
Q1 2023$264,844,442
+15.6%
29,993,7080.0%1.24%
+8.4%
Q4 2022$229,151,929
+7.3%
29,993,7080.0%1.15%
+16.3%
Q3 2022$213,555,000
-12.0%
29,993,7080.0%0.99%
-11.2%
Q2 2022$242,649,000
-41.7%
29,993,7080.0%1.11%
-34.0%
Q1 2022$416,313,000
-50.5%
29,993,7080.0%1.68%
-30.6%
Q4 2021$841,623,000
-17.4%
29,993,7080.0%2.42%
-13.3%
Q3 2021$1,019,486,000
-16.8%
29,993,7080.0%2.80%
-24.8%
Q2 2021$1,225,543,000
+1.5%
29,993,7080.0%3.72%
+3.3%
Q1 2021$1,207,547,000
-31.9%
29,993,7080.0%3.60%
-26.3%
Q4 2020$1,773,528,000
+8.9%
29,993,708
-10.4%
4.88%
-17.1%
Q3 2020$1,628,799,000
+0.5%
33,493,7080.0%5.88%
-16.0%
Q2 2020$1,620,426,000
+74.2%
33,493,7080.0%7.00%
+44.6%
Q1 2020$930,455,000
-19.0%
33,493,708
-12.8%
4.84%
-10.0%
Q4 2019$1,149,126,000
-3.2%
38,406,6070.0%5.38%
-12.9%
Q3 2019$1,186,764,000
-36.0%
38,406,6070.0%6.18%
-25.7%
Q2 2019$1,855,039,00038,406,6078.32%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2022
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders